Related references
Note: Only part of the references are listed.Halogenated Pyrrolopyrimidines with Low MIC on Staphylococcus aureus and Synergistic Effects with an Antimicrobial Peptide
Cecilie Elisabeth Olsen et al.
ANTIBIOTICS-BASEL (2022)
First-in-human safety, pharmacokinetics, and preliminary efficacy of TPX-0022, a novel inhibitor of MET/SRC/CSF1R in patients with advanced solid tumors harboring genetic alterations in MET
D. Hong et al.
EUROPEAN JOURNAL OF CANCER (2020)
The M-CSF receptor in osteoclasts and beyond
Se Hwan Mun et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach
Jonas Lategahn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Overexpression and activation of colony-stimulating factor 1 receptor in the SIV/macaque model of HIV infection and neuroHIV
Derek L. Irons et al.
BRAIN PATHOLOGY (2019)
Potent and selective EGFR inhibitors based on 5-aryl-7H-pyrrolopyrimidin-4-amines
Ann Christin Reiersolmoen et al.
BIOORGANIC CHEMISTRY (2019)
Synthesis of 1,4-and 1,5-Amino Alcohols via Nucleophilic Addition of Semicyclic N,O-Acetal with Organozinc Reagents
Xue-Mei Wang et al.
JOURNAL OF ORGANIC CHEMISTRY (2019)
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
Jonas Lategahn et al.
CHEMICAL SCIENCE (2019)
What Makes a Kinase Promiscuous for Inhibitors?
Sonya M. Hanson et al.
CELL CHEMICAL BIOLOGY (2019)
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability
Kenichi Iwai et al.
EMBO MOLECULAR MEDICINE (2018)
Identification of fused pyrimidines as interleukin 17 secretion inhibitors
Ann Christin Reiersolmoen et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Identification of N-{cis-3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)aminolcyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases
Michael L. Vazquez et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Early long-term administration of the CSF1R inhibitor PLX3397 ablates microglia and reduces accumulation of intraneuronal amyloid, neuritic plaque deposition and pre-fibrillar oligomers in 5XFAD mouse model of Alzheimer's disease
Justyna Sosna et al.
MOLECULAR NEURODEGENERATION (2018)
High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers
Muhammad Baghdadi et al.
SCIENTIFIC REPORTS (2018)
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88L265P Diffuse Large B-Cell Lymphoma
James S. Scott et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer's-like pathology
Adrian Olmos-Alonso et al.
BRAIN (2016)
Family-wide Structural Analysis of Human Numb-Associated Protein Kinases
Fiona J. Sorrell et al.
STRUCTURE (2016)
The interaction of anticancer therapies with tumor-associated macrophages
Alberto Mantovani et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor
W. D. Tap et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Discovery and Preclinical Profiling of 3-[4-(Morpholin-4-yl)-7H-pyrrolo[2,3-d]pyrimidin-5-yl]benzonitrile (PF-06447475), A Highly Potent, Selective, Brain Penetrant, and in Vivo Active LRRK2 Kinase Inhibitor
Jaclyn L. Henderson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Phenotypic and metabolic investigation of a CSF-1R kinase receptor inhibitor (BLZ945) and its pharmacologically active metabolite
Joel A. Krauser et al.
XENOBIOTICA (2015)
The journey from stem cell to macrophage
Mikael J. Pittet et al.
YEAR IN IMMUNOLOGY: MYELOID CELLS AND INFLAMMATION (2014)
Macrophage Regulation of Tumor Responses to Anticancer Therapies
Michele De Palma et al.
CANCER CELL (2013)
Macrophage biology in development, homeostasis and disease
Thomas A. Wynn et al.
NATURE (2013)
Characterization of kinase inhibitors using different phosphorylation states of colony stimulating factor-1 receptor tyrosine kinase
Daisuke Kitagawa et al.
JOURNAL OF BIOCHEMISTRY (2012)
Prognostic Significance of Tumor-Associated Macrophages in Solid Tumor: A Meta-Analysis of the Literature
Qiong-wen Zhang et al.
PLOS ONE (2012)
Nickel-catalyzed Negishi cross-couplings of 6-chloropurines with organozinc halides at room temperature
Dong-Chao Wang et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2011)
Activation State-Dependent Binding of Small Molecule Kinase Inhibitors: Structural Insights from Biochemistry
Lisa M. Wodicka et al.
CHEMISTRY & BIOLOGY (2010)
CSF1R copy number changes, point mutations, and RNA and protein overexpression in renal cell carcinomas
Maria J. Soares et al.
MODERN PATHOLOGY (2009)
The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Cai-Hong Yun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Discovery of a cytokine and its receptor by functional screening of the extracellular proteome
Haishan Lin et al.
SCIENCE (2008)
Convenient titration method for organometallic zinc, magnesium, and lanthanide reagents
A Krasovskiy et al.
SYNTHESIS-STUTTGART (2006)
Share Paper
